ASX 200 financial shares are outperforming on Friday.
The S&P/ASX 200 Financials Index (ASX: XFJ) is currently up 0.2% while the S&P/ASX 200 Index (ASX: XJO) is down 0.16%.
As earnings season continues, the following two financial sector companies have revealed their latest reports.
The reports prompted experts to reassess their ratings and 12-month price targets on these ASX 200 financial shares.
Let's take a look.
Image Source: Getty Images
Insurance Australia Group Ltd (ASX: IAG)
The IAG share price is 2.2% higher at $7.11 on Friday.
Last week, the insurance giant reported a 23% revenue lift to $11.14 billion but a 35.1% decrease in net profit after tax (NPAT) for 1H FY26.
After reviewing the numbers, the experts have revised their ratings and 12-month targets.
Jarden reiterated its buy rating and shaved its share price target down from $8.20 to $8.10.
Jefferies also kept a buy rating with a price target of $9.20.
JP Morgan kept its buy rating on IAG shares with a price target of $7.70.
Macquarie reiterated its buy rating with a price target of $9.
UBS maintained its buy rating with a price target of $9.
Morgan Stanley kept its hold rating and reduced its price target from $8.45 to $7.50.
The IAG share price reached an all-time high of $9.18 in June 2025.
AMP Ltd (ASX: AMP)
The AMP share price is down 1% to $1.36 at the time of writing.
Last week, AMP reported its full-year FY25 results.
AMP reported a 20.8% lift in underlying NPAT to $285 million, but an 11.3% fall in statutory NPAT to $133 million.
The wealth manager said the statutory NPAT decline reflected legacy legal settlements.
The AMP share price tumbled 27% on the news and experienced its biggest intraday fall since 2003.
Brokers have reviewed the report and reassessed their ratings and targets.
Jarden upgraded AMP shares to a buy but reduced its 12-month price target from $1.85 to $1.65.
Morgan Stanley retained its buy rating on the ASX 200 financial share with a lowered price target of $1.90 (from $2.20).
Jefferies also kept a buy rating with a price target of $1.75.
Ord Minnett upgraded AMP shares to a buy but cut its target from $2.05 to $1.65.
Citi reiterated its buy rating but reduced its 12-month price target from $2.10 to $1.80.
UBS maintained its buy rating and lowered its target from $1.90 to $1.75.
Macquarie kept its buy rating with a price target of $1.80.
The AMP share price hit a 52-week high of $13.73 in August 2025.
